Medicamen Biotech Future Growth

Future criteria checks 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for Medicamen Biotech.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Pharmaceuticals earnings growth	18.0%
Revenue growth rate	n/a
Future return on equity	n/a
Analyst coverage	None
Last updated	n/a

Recent future growth updates

No updates

Recent updates

Medicamen Biotech Limited's (NSE:MEDICAMEQ) P/S Is Still On The Mark Following 41% Share Price Bounce

Sep 28

Medicamen Biotech (NSE:MEDICAMEQ) Will Pay A Dividend Of ₹1.00

Sep 03

Medicamen Biotech (NSE:MEDICAMEQ) Is Due To Pay A Dividend Of ₹1.00

Aug 16

These 4 Measures Indicate That Medicamen Biotech (NSE:MEDICAMEQ) Is Using Debt Extensively

Jul 04

What Medicamen Biotech Limited's (NSE:MEDICAMEQ) 28% Share Price Gain Is Not Telling You

May 21

More Unpleasant Surprises Could Be In Store For Medicamen Biotech Limited's (NSE:MEDICAMEQ) Shares After Tumbling 26%

Mar 17

Medicamen Biotech (NSE:MEDICAMEQ) Will Pay A Dividend Of ₹1.00

Sep 13

Why Medicamen Biotech's (NSE:MEDICAMEQ) Shaky Earnings Are Just The Beginning Of Its Problems

Nov 19

There's Reason For Concern Over Medicamen Biotech Limited's (NSE:MEDICAMEQ) Price

Dec 03

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Medicamen Biotech has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

Earnings and Revenue Growth Forecasts

NSEI:MEDICAMEQ - Analysts future estimates and past financials data (INR Millions)
Date	Revenue	Earnings	Free Cash Flow	Cash from Op	Avg. No. Analysts
6/30/2024	1,804	81	N/A	N/A	N/A
3/31/2024	1,793	109	-130	-67	N/A
12/31/2023	1,707	127	N/A	N/A	N/A
9/30/2023	1,597	133	-174	-106	N/A
6/30/2023	1,497	154	N/A	N/A	N/A
3/31/2023	1,409	148	-129	-63	N/A
12/31/2022	1,250	137	N/A	N/A	N/A
9/30/2022	1,220	137	-51	9	N/A
6/30/2022	1,210	143	N/A	N/A	N/A
3/31/2022	1,154	149	-45	41	N/A
12/31/2021	1,139	158	N/A	N/A	N/A
9/30/2021	1,142	150	-44	99	N/A
6/30/2021	1,125	140	N/A	N/A	N/A
3/31/2021	1,127	121	-52	128	N/A
12/31/2020	1,150	110	N/A	N/A	N/A
9/30/2020	1,174	116	-271	6	N/A
6/30/2020	1,222	123	N/A	N/A	N/A
3/31/2020	1,255	133	-248	128	N/A
12/31/2019	1,353	136	N/A	N/A	N/A
9/30/2019	1,241	124	N/A	N/A	N/A
6/30/2019	1,210	123	N/A	N/A	N/A
3/31/2019	1,227	120	-114	43	N/A
12/31/2018	1,187	110	N/A	N/A	N/A
9/30/2018	1,229	117	N/A	N/A	N/A
6/30/2018	1,183	108	N/A	N/A	N/A
3/31/2018	1,115	101	N/A	-55	N/A
12/31/2017	1,045	94	N/A	N/A	N/A
9/30/2017	962	81	N/A	N/A	N/A
6/30/2017	912	65	N/A	N/A	N/A
3/31/2017	825	52	N/A	36	N/A
12/31/2016	782	58	N/A	N/A	N/A
9/30/2016	723	26	N/A	N/A	N/A
6/30/2016	673	18	N/A	N/A	N/A
3/31/2016	673	5	N/A	62	N/A
12/31/2015	679	-13	N/A	N/A	N/A
9/30/2015	667	-2	N/A	N/A	N/A
6/30/2015	760	-1	N/A	N/A	N/A
3/31/2015	779	4	N/A	-33	N/A
12/31/2014	816	0	N/A	N/A	N/A
9/30/2014	807	-1	N/A	N/A	N/A
6/30/2014	738	-1	N/A	N/A	N/A
3/31/2014	732	1	N/A	51	N/A
12/31/2013	696	-7	N/A	N/A	N/A
9/30/2013	697	-20	N/A	N/A	N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if MEDICAMEQ's forecast earnings growth is above the savings rate (6.7%).

Earnings vs Market: Insufficient data to determine if MEDICAMEQ's earnings are forecast to grow faster than the Indian market

High Growth Earnings: Insufficient data to determine if MEDICAMEQ's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: Insufficient data to determine if MEDICAMEQ's revenue is forecast to grow faster than the Indian market.

High Growth Revenue: Insufficient data to determine if MEDICAMEQ's revenue is forecast to grow faster than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if MEDICAMEQ's Return on Equity is forecast to be high in 3 years time

Medicamen Biotech Future Growth

Future criteria checks 0/6

Key information

Recent future growth updates

Recent updates

Medicamen Biotech Limited's (NSE:MEDICAMEQ) P/S Is Still On The Mark Following 41% Share Price Bounce

Upcoming dividend of ₹1.00 per share

Medicamen Biotech (NSE:MEDICAMEQ) Will Pay A Dividend Of ₹1.00

Medicamen Biotech (NSE:MEDICAMEQ) Is Due To Pay A Dividend Of ₹1.00

Dividend of ₹1.00 announced

First quarter 2025 earnings released: EPS: ₹0.63 (vs ₹3.12 in 1Q 2024)

Medicamen Biotech Limited, Annual General Meeting, Sep 26, 2024

Medicamen Biotech Limited to Report Q1, 2025 Results on Aug 13, 2024

Medicamen Biotech Limited Announces the Resignation of Pratap Rawat as Chief Financial Officer, Effective August 14, 2024

Investor sentiment improves as stock rises 17%

These 4 Measures Indicate That Medicamen Biotech (NSE:MEDICAMEQ) Is Using Debt Extensively

Full year 2024 earnings released: EPS: ₹7.50 (vs ₹11.92 in FY 2023)

Medicamen Biotech Limited to Report Q4, 2024 Results on May 29, 2024

What Medicamen Biotech Limited's (NSE:MEDICAMEQ) 28% Share Price Gain Is Not Telling You

Investor sentiment improves as stock rises 16%

Investor sentiment improves as stock rises 17%

More Unpleasant Surprises Could Be In Store For Medicamen Biotech Limited's (NSE:MEDICAMEQ) Shares After Tumbling 26%

Investor sentiment deteriorates as stock falls 19%

Third quarter 2024 earnings released: EPS: ₹1.60 (vs ₹2.98 in 3Q 2023)

Medicamen Biotech Limited to Report Q3, 2024 Results on Feb 12, 2024

Second quarter 2024 earnings released: EPS: ₹1.17 (vs ₹2.85 in 2Q 2023)

Medicamen Biotech Limited to Report Q2, 2024 Results on Nov 10, 2023

Investor sentiment improves as stock rises 17%

New minor risk - Market cap size

Upcoming dividend of ₹1.00 per share at 0.1% yield

Medicamen Biotech (NSE:MEDICAMEQ) Will Pay A Dividend Of ₹1.00

Medicamen Biotech Limited, Annual General Meeting, Sep 27, 2023

First quarter 2024 earnings released: EPS: ₹3.12 (vs ₹2.94 in 1Q 2023)

Medicamen Biotech Limited to Report Q1, 2024 Results on Aug 08, 2023

Full year 2023 earnings released: EPS: ₹11.82 (vs ₹12.19 in FY 2022)

Medicamen Biotech Limited to Report Q4, 2023 Results on May 29, 2023

Third quarter 2023 earnings released: EPS: ₹2.98 (vs ₹3.09 in 3Q 2022)

Medicamen Biotech Limited to Report Q3, 2023 Results on Feb 10, 2023

Why Medicamen Biotech's (NSE:MEDICAMEQ) Shaky Earnings Are Just The Beginning Of Its Problems

Second quarter 2023 earnings released: EPS: ₹2.85 (vs ₹3.46 in 2Q 2022)

Insufficient new directors

Second quarter 2023 earnings released: EPS: ₹2.85 (vs ₹3.46 in 2Q 2022)

Medicamen Biotech Limited to Report Q2, 2023 Results on Nov 11, 2022

Investor sentiment improved over the past week

First quarter 2023 earnings released: EPS: ₹2.94 (vs ₹3.40 in 1Q 2022)

Medicamen Biotech Limited, Annual General Meeting, Sep 27, 2022

Investor sentiment improved over the past week

Full year 2022 earnings released: EPS: ₹12.19 (vs ₹9.93 in FY 2021)

Medicamen Biotech Limited to Report Q4, 2022 Results on May 25, 2022

Insufficient new directors

Investor sentiment improved over the past week

Insufficient new directors

Insufficient new directors

Investor sentiment deteriorated over the past week

Third quarter 2022 earnings: Revenues and EPS in line with analyst expectations

Medicamen Biotech Limited to Report Q3, 2022 Results on Feb 08, 2022

Investor sentiment improved over the past week

There's Reason For Concern Over Medicamen Biotech Limited's (NSE:MEDICAMEQ) Price

Investor sentiment improved over the past week

Second quarter 2022 earnings released: EPS ₹3.46 (vs ₹2.64 in 2Q 2021)

Earnings and Revenue Growth Forecasts

Analyst Future Growth Forecasts

Earnings per Share Growth Forecasts

Future Return on Equity

Discover growth companies